Famotidine ( DrugBank: Famotidine )

5 diseases

6. パーキンソン病

臨床試験数 : 2,307 / 薬物数 : 2,007 - (DrugBank : 349) / 標的遺伝子数 : 188 - 標的パスウェイ数 : 199

diseases per page:

Showing 1 to 1 of 1 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT01937078 (ClinicalTrials.gov)	April 2011	26/7/2012	Famotidine for Levodopa-induced Dyskinesia in PD	An 'N-of-1' Study of the Histamine H@ Antagonist, Famotidinein Levodopa-induced Dyskinesia in Parkin ...	Dyskinesia	Drug: Famotidine	University Health Network, Toronto	NULL	Completed	18 Years	80 Years	Both	7	Phase 2	Canada

臨床試験数 : 4,356 / 薬物数 : 2,567 - (DrugBank : 415) / 標的遺伝子数 : 192 - 標的パスウェイ数 : 228

diseases per page:

Showing 1 to 2 of 2 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	JPRN-UMIN000004271	2009/04/01	27/09/2010	Upper gastrointestinal endoscopic findings in Japanese with rheumatoid arthritis (RA) receiving long ...	Upper gastrointestinal endoscopic findings in Japanese with rheumatoid arthritis (RA) receiving long ...	Rheumatoid arthritis (RA)NSAIDs-induced gastrointestinal mucosal injury	Japanese rheumatic patients who have been treated with NSAIDs for twelve or more weeks are switched ...	Hoshigaoka Koseinenkin Hospital	NULL	Complete: follow-up complete	20years-old	Not applicable	Male and Female	100	Not applicable	Japan
2	NCT00613106 (ClinicalTrials.gov)	September 2007	28/1/2008	Double-Blind Follow-on Safety Study of HZT-501 (Ibuprofen 800 mg/Famotidine26.6 mg) in Subjects Who ...	Double-Blind Follow-On Safety Study of HZT-501 (Ibuprofen 800 mg/Famotidine26.6 mg)in Subjects Who H ...	Osteoarthritis;Rheumatoid Arthritis;Chronic Low Back Pain;Chronic Regional Pain Syndrome;Chronic Sof ...	Drug: HZT-501;Drug: Ibuprofen	Horizon Pharma Ireland, Ltd., Dublin Ireland	NULL	Completed	40 Years	81 Years	All	179	Phase 3	United States

臨床試験数 : 1,205 / 薬物数 : 684 - (DrugBank : 124) / 標的遺伝子数 : 100 - 標的パスウェイ数 : 193

diseases per page:

Showing 1 to 1 of 1 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT03554291 (ClinicalTrials.gov)	May 1, 2019	31/5/2018	Repurposing a Histamine Antagonist to Benefit Patients With Pulmonary Hypertension	Repurposing a Histamine Antagonist to Benefit Patients With Pulmonary Hypertension	Pulmonary Arterial Hypertension;Right Heart Failure	Drug: Famotidine 20 MG;Other: Placebo	University of Washington	National Heart, Lung, and Blood Institute (NHLBI)	Recruiting	18 Years	80 Years	All	80	Phase 2	United States

臨床試験数 : 172 / 薬物数 : 149 - (DrugBank : 39) / 標的遺伝子数 : 38 - 標的パスウェイ数 : 135

diseases per page:

Showing 1 to 1 of 1 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT04248712 (ClinicalTrials.gov)	July 10, 2020	28/1/2020	Antihistamines in Eosinophilic Esophagitis	A Phase II, Randomized, Placebo-controlled Study Evaluating the Efficacy of Antihistamines in the Tr ...	Eosinophilic Esophagitis	Drug: Famotidine;Drug: Loratadine;Drug: Placebo	Mayo Clinic	NULL	Terminated	18 Years	N/A	All	1	Phase 2	United States

臨床試験数 : 447 / 薬物数 : 297 - (DrugBank : 57) / 標的遺伝子数 : 52 - 標的パスウェイ数 : 146

diseases per page:

Showing 1 to 1 of 1 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT01563185 (ClinicalTrials.gov)	April 2012	20/3/2012	Open-label Safety and Pharmacokinetic Study of DUEXIS® (Ibuprofen and Famotidine) Tablets in Juvenil ...	A Multicenter, Open-label Safety and Pharmacokinetic Study of DUEXIS® (Ibuprofen and Famotidine) Tab ...	Juvenile Idiopathic Arthritis	Drug: 800 mg ibuprofen/26.6 mg famotidine	Horizon Pharma Ireland, Ltd., Dublin Ireland	Pediatric Rheumatology Collaborative Study Group	Completed	10 Years	16 Years	All	12	Phase 4	United States